Meda Eyes Its Own Deals After Spurning $24B Mylan Tie-Up
By Karlee Weinmann ( May 7, 2014, 4:06 PM EDT) -- Swedish drugmaker Meda AB said Wednesday that it sees itself as a buyer — not a target — and would eye "major acquisitions" to help double its size after twice rebuffing a $24 billion merger proposal from bigger rival Mylan Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.